MUNDIPHARMA has welcomed the announcement by Federal Health Minister Greg Hunt that Nyxoid (naloxone 1.8mg) nasal spray has been registered in Australia as an easy-to-administer, fast-acting and potentially lifesaving antidote to opioid overdose.
Registered as an S3 medicine, this delivery form is expected to be available "by the end of the year".
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Sep 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Sep 18
